Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sarepta Drug Could Benefit From Duchenne Muscular Dystrophy Patient Study
Sarepta Drug Could Benefit From Duchenne Muscular Dystrophy Patient Study
Sarepta Drug Could Benefit From Duchenne Muscular Dystrophy Patient Study
Submitted by
admin
on October 13, 2014 - 4:09pm
Source:
The Chairman's Blog
News Tags:
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Headline:
Sarepta Drug Could Benefit From Duchenne Muscular Dystrophy Patient Study
Do Not Allow Advertisers to Use My Personal information
